Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceutical
Pharma
Apellis hit with yet another eye drug snub in Europe
Amid a parade of regulatory endorsements in Europe, Apellis’ ophthalmology prospect pegcetacoplan has been left in the cold once again.
Fraiser Kansteiner
Sep 20, 2024 10:06am
Teva inks $80M opioid settlement with Baltimore
Sep 9, 2024 5:05pm
Teva faces fresh Copaxone kickbacks lawsuit
Aug 20, 2024 1:12pm
FTC launches investigation into Teva's inhaler patents: report
Jul 2, 2024 10:02am
Teva to end years of Israel tax litigation with $750M deal
Jun 25, 2024 1:01pm
The top 10 best-paid CEOs in Big Pharma in 2023
Jun 17, 2024 3:00am
